Clinica Baviera (CBAV) Price & Analysis

Compare

8 Followers

CBAV Stock Chart & Stats

€47.30

€0.20(0.61%)

At close: Jan 09 4:00 PM EST

€47.30

€0.20(0.61%)

Day’s Range― - ―

52-Week Range€29.70 - €56.60

Previous CloseN/A

Volume285.00

Average Volume (3M)2.20K

Market Cap

€864.08M

Enterprise Value€871.40M

Total Cash (Recent Filing)€43.85M

Total Debt (Recent Filing)€66.61M

Price to Earnings (P/E)20.5

Beta0.52

Next Earnings

Mar 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield3.31%

Share Statistics

EPS (TTM)0.34

Shares Outstanding16,307,580

10 Day Avg. Volume2,444

30 Day Avg. Volume2,202

Financial Highlights & Ratios

PEG Ratio1.07

Price to Book (P/B)5.24

Price to Sales (P/S)1.93

P/FCF Ratio14.01

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

High Profitability And MarginsHigh gross and operating margins reflect efficient clinical workflows, specialized procedures and pricing power. Durable margin levels give the company sustained internal funding for upgrades, R&D and shareholder returns, insulating profits from short-term volume swings.

Very Low Leverage With Strong ROEExtremely low leverage combined with a high ROE indicates efficient capital use and strong shareholder returns. This balance sheet strength provides durable financial flexibility to invest in clinics, technology or M&A without materially increasing financing risk over the medium term.

Healthy Cash GenerationConsistent free cash flow growth and operating cash that exceeds net income demonstrate reliable cash conversion. This durable cash generation supports capital expenditure, dividend policy and opportunistic investments without dependence on external capital markets.

Bears Say

Mature Growth PhaseSlowing top-line growth signals a matured market position; absent geographic expansion, service diversification or acquisitions, organic revenue upside may be limited. This structural constraint could cap medium-term earnings growth and returns.

Declining Equity Ratio TrendA falling equity ratio erodes the capital buffer and reduces resilience to adverse shocks. If the trend continues, the company may face pressure to raise debt or equity, which could constrain strategic initiatives and increase financial risk over the coming 2–6 months.

Concentration On Procedural RevenueHeavy reliance on surgical and procedural services links financial performance to patient volumes, reimbursement and elective care demand. This structural concentration raises vulnerability to demographic, policy or demand shifts unless the company broadens services or payer mix.

Clinica Baviera News

Clínica Baviera Shareholders Approve Key Proposals at General Meeting

The latest update is out from Clinica Baviera ( ($ES:CBAV) ). The Ordinary General Meeting of Shareholders of...

9M ago

Clínica Baviera Appoints New Vice Presidents to Board

Clinica Baviera ( ($ES:CBAV) ) has provided an update. Clínica Baviera has announced the appointment of Ms. Yongmei...

9M ago

Clinica Baviera Proposes New Director Remuneration Policy for 2025-2028

Clinica Baviera ( ($ES:CBAV) ) just unveiled an update. Clinica Baviera, S.A. has announced its remuneration policy for...

10M ago

Clínica Baviera Announces Ordinary General Meeting of Shareholders

Clinica Baviera ( ($ES:CBAV) ) has shared an update. Clínica Baviera’s Board of Directors has announced the convening...

10M ago

Clinica Baviera Announces 2024 Dividend Details

Clinica Baviera ( ($ES:CBAV) ) has provided an announcement. Clinica Baviera has announced the details of its upcoming...

10M ago

Clínica Baviera Share Sale Targets Qualified Investors

Clinica Baviera ( ($ES:CBAV) ) has issued an update. Aier Eye International (Europe), S.L.U. and Vito Gestión Patrimonial,...

11M ago

Clínica Baviera Share Sale Targeting Qualified Investors

Clinica Baviera ( ($ES:CBAV) ) just unveiled an announcement. Aier Eye International (Europe) and Vito Gestión Patrimonial are...

11M ago

Clinica Baviera Proposes 2024 Dividend Distribution

An update from Clinica Baviera ( ($ES:CBAV) ) is now available. The Board of Directors of Clinica Baviera...

11M ago

Clinica Baviera Reports 2024 Liquidity Operations

Clinica Baviera (ES:CBAV) has released an update. Clinica Baviera has reported its liquidity contract operations for the last...

1y ago

Clínica Baviera Appoints New Director and Audit Chair

Clinica Baviera (ES:CBAV) has released an update. Clínica Baviera has appointed Carolina Martínez-Caro as a new independent director,...

1y ago

CBAV FAQ

What was Clinica Baviera, SA’s price range in the past 12 months?

Clinica Baviera, SA lowest stock price was €29.70 and its highest was €56.60 in the past 12 months.

What is Clinica Baviera, SA’s market cap?

Clinica Baviera, SA’s market cap is €864.08M.

When is Clinica Baviera, SA’s upcoming earnings report date?

Clinica Baviera, SA’s upcoming earnings report date is Mar 04, 2026 which is in 15 days.

How were Clinica Baviera, SA’s earnings last quarter?

Clinica Baviera, SA released its earnings results on Nov 06, 2025. The company reported €0.343 earnings per share for the quarter, beating the consensus estimate of N/A by €0.343.

Is Clinica Baviera, SA overvalued?

According to Wall Street analysts Clinica Baviera, SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Clinica Baviera, SA pay dividends?

Clinica Baviera, SA pays a Annually dividend of €1.57 which represents an annual dividend yield of 3.31%. See more information on Clinica Baviera, SA dividends here

What is Clinica Baviera, SA’s EPS estimate?

Clinica Baviera, SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Clinica Baviera, SA have?

Clinica Baviera, SA has 16,307,580 shares outstanding.

What happened to Clinica Baviera, SA’s price movement after its last earnings report?

Clinica Baviera, SA reported an EPS of €0.343 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.971%.

Which hedge fund is a major shareholder of Clinica Baviera, SA?

Currently, no hedge funds are holding shares in ES:CBAV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Clinica Baviera, SA

Clinica Baviera (CBAV) is a leading provider of ophthalmological services in Spain and several other countries, specializing in vision correction procedures such as LASIK and cataract surgery. The clinic operates a network of medical centers equipped with advanced technology and staffed by highly trained professionals to deliver quality eye care. In addition to surgical interventions, Clinica Baviera offers comprehensive eye examinations, diagnostic services, and post-operative care, focusing on improving patients' quality of life through enhanced vision.